PGD2 receptor antagonists for the treatment of inflammatory...

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S159000, C514S313000, C514S314000

Reexamination Certificate

active

10678872

ABSTRACT:
Disclosed herein are compounds represented by Structural Formula (I):(I), wherein the variables are defined herein.Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2 (“CRTH2”) for the treatment of inflammatory disorders.

REFERENCES:
patent: 5258510 (1993-11-01), Ogawa et al.
patent: 6048873 (2000-04-01), Vasudevan et al.
patent: 6147089 (2000-11-01), DeNinno et al.
patent: 6197786 (2001-03-01), DeNinno et al.
patent: 6291677 (2001-09-01), Vasudevan et al.
patent: 6310075 (2001-10-01), DeNinno et al.
patent: 6313107 (2001-11-01), Vasudevan et al.
patent: 6313142 (2001-11-01), Damon et al.
patent: 6362198 (2002-03-01), Goldstein et al.
patent: 6362199 (2002-03-01), DiFabio
patent: 6395751 (2002-05-01), DeNinno et al.
patent: 6489478 (2002-12-01), DeNinno et al.
patent: 6586448 (2003-07-01), DeNinno et al.
patent: 6600045 (2003-07-01), Damon et al.
patent: 2002/0022218 (2002-02-01), Li et al.
patent: 0987251 (2000-03-01), None
patent: 0992496 (2000-04-01), None
patent: 1125929 (2001-08-01), None
patent: 1221439 (2002-07-01), None
patent: P200253557 (2002-02-01), None
patent: WO 91/05549 (1991-05-01), None
patent: WO 94/01113 (1994-01-01), None
patent: WO 0006153 (2000-02-01), None
patent: WO 0017165 (2000-03-01), None
patent: WO 0017166 (2000-03-01), None
patent: WO 0140190 (2001-06-01), None
patent: WO 0149675 (2001-07-01), None
patent: WO 0158875 (2001-08-01), None
patent: WO 0176629 (2001-10-01), None
patent: WO 0211710 (2002-02-01), None
patent: WO 0218361 (2002-03-01), None
patent: WO 0222585 (2002-03-01), None
patent: WO 02058652 (2002-08-01), None
patent: WO 02079165 (2002-10-01), None
patent: WO 02088069 (2002-11-01), None
patent: WO 03097042 (2003-11-01), None
patent: WO 03097598 (2003-11-01), None
patent: WO 03105849 (2003-12-01), None
patent: WO 2004/035543 (2004-04-01), None
patent: WO04052863 (2004-06-01), None
patent: WO05007094 (2006-12-01), None
Funabashi, CA 72:31075, 1969.
Zalukajevs, CA 48:56687, 1951.
Zalukajevs, CA 62:22149, 1964.
Zalukajevs, CA 59:54789, 1963.
Zalukaev, CA 67:53250, 1967.
Zalukaev, CA 65:81601, 1966.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

PGD2 receptor antagonists for the treatment of inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PGD2 receptor antagonists for the treatment of inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PGD2 receptor antagonists for the treatment of inflammatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3761105

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.